{
    "code": 0,
    "data": [
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Wednesday February 11 2026",
            "news_body": "Please find the enclosed financials of the Company for the quarter ended December 31 2025 for your reference.",
            "news_id": "40bfbe75-8e0f-4dec-bc2e-4e4d1a975fad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c12ed04e-e85b-4410-b25c-abb0ed976195.pdf",
            "news_date": "2026-02-11 19:00:19",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Friday November 7 2025",
            "news_body": "Please find the enclosed document as per the captioned subject.",
            "news_id": "6269155e-345c-44dc-a798-102bf981a73e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d93ebb7e-7e4b-4670-81e7-a59ce5368816.pdf",
            "news_date": "2025-11-07 17:45:55",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Thursday August 14 2025",
            "news_body": "Please find the enclosed Financial Results for the quarter ended June 30 2025.",
            "news_id": "1f0791e2-a265-4d23-8df8-5fd8c03c52ac",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48cf5f79-c911-46e4-9d72-4828940b3d02.pdf",
            "news_date": "2025-08-14 14:09:53",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Tuesday February 11 2025",
            "news_body": "Please find the enclosed document as per the captioned subject for your reference.",
            "news_id": "e7a10119-717b-41d3-b93c-711f25e23bad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=497a6e78-e729-4993-828e-4ce935acc5e5.pdf",
            "news_date": "2025-02-11 19:16:37",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Wednesday, November 13, 2024",
            "news_body": "Please find the enclosed financial results for the quarter and half year ended September 30, 2024.",
            "news_id": "873556d1-b871-4a20-9da9-b718d50f8631",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae1be72d-43b2-45e5-b9c0-4d7ca1511174.pdf",
            "news_date": "2024-11-13 16:37:46",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Thursday, August 8, 2024",
            "news_body": "Please find the enclosed financial results for the quarter ended June 30, 2024.",
            "news_id": "f0eaad3f-e351-4898-a203-6c799d568522",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f338c2fc-b916-405f-996d-109cead7d259.pdf",
            "news_date": "2024-08-08 14:49:50",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Monday, May 27, 2024",
            "news_body": "The Board of Directors of the Company at its meeting held today, i.e., May 27, 2024 has inter alia 1. Approved the audited financial results of the Company for the quarter and year ended March 31, 2024. The said audited financial results together with the audit report  of the statutory auditors dated May 27, 2024 is enclosed.2. Recommended dividend of Rs. 24 per equity share for the FY 2023-24",
            "news_id": "bf2d7425-a0d2-4660-a153-9674727ecb20",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f5a744f-148f-454e-8a74-fc214d8e0396.pdf",
            "news_date": "2024-05-27 17:40:35",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Thursday, February 8, 2024",
            "news_body": "Please find enclosed copy of the Financial Results for the quarter ended December 31, 2023.",
            "news_id": "8941ed94-064d-45ac-a232-7fdad3dba8f6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a66fbe35-d692-41bb-8bfc-7a112b101971.pdf",
            "news_date": "2024-02-08 18:17:19",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Thursday, November 9, 2023",
            "news_body": "At the Board Meeting of the Company held on Thursday, November 9, 2023, the Board of Directors considered and approved the Unaudited Financial Results for the quarter ended September 30, 2023.",
            "news_id": "ffd60617-9ee7-48b7-b425-28e91fd80c26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5212d907-36a3-43b5-8c36-86e1f1c2c375.pdf",
            "news_date": "2023-11-09 17:10:33",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Monday, August 14, 2023",
            "news_body": "At the Board Meeting of the Company held on Monday, August 14, 2023, the Board of Directors considered and approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2023. The said Unaudited Financial Results together with the Limited Review report of the Statutory Auditors dated August 14, 2023 are enclosed herewith.<BR> <BR> The Board Meeting started at 10:30 am and concluded at 1:30 pm.",
            "news_id": "4322739a-3427-4dd6-9551-e59095e36749",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=848fc6a1-df83-4a0e-9bc0-b538b514a1e4.pdf",
            "news_date": "2023-08-14 13:51:47",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday, August 14, 2023",
            "news_body": "At the Board Meeting of the Company held on Monday, August 14, 2023, the Board of Directors considered and approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2023. The said Unaudited Financial Results together with the Limited Review report of the Statutory Auditors dated August 14, 2023 are enclosed herewith.<BR> <BR> The Board Meeting started at 10:30 a.m and concluded at 1:30 p.m.",
            "news_id": "312c83cf-7260-4b69-bd79-4280f12a9b7e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26b71bd7-c7b4-4173-9281-74da29c8d92c.pdf",
            "news_date": "2023-08-14 13:46:49",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, May 30, 2023",
            "news_body": "The Board of Directors of the Company at its Meeting held today i.e., May 30, 2023, has inter-alia:<BR> <BR> 1. Approved the Audited Financial Results of the Company for the quarter and year ended                           March 31, 2023. The said Audited Financial Results together with the Audit report of the Statutory Auditors dated May 30, 2023 are enclosed herewith. <BR> <BR> 2. Recommended Dividend of Rs. 16/- per equity share for the Financial Year 2022-23.<BR> <BR> We also confirm that the Statutory Auditor's Report is with unmodified opinion in respect of the Audited Financial Results of the Company for the Financial Year ended March 31, 2023. <BR> <BR> The Board Meeting concluded at 4:30 p.m.<BR> <BR> Please take the same on record.<BR>",
            "news_id": "33350762-4703-4fd4-8902-93fe4330b768",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eea7e19e-b140-4fab-9ad6-27d622c17865.pdf",
            "news_date": "2023-05-30 16:42:06",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Friday, February 10, 2023 Pursuant To Regulations 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In continuation of our letter dated January 30, 2023, we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e., Friday, February 10, 2023 inter alia considered and approved the Unaudited Financial Results for the quarter ended December 31, 2022 based on the recommendation of the Audit Committee. The said Unaudited Financial Results together with the Limited Review Report of the Statutory Auditors dated February 10, 2023 are enclosed herewith. <BR> <BR> The Meeting commenced at 2:30 P.M. and concluded at 5.00 P.M. (IST).<BR> <BR> Kindly take the above information on your records. <BR> <BR>",
            "news_id": "a0425721-72c6-41f1-8a45-08a95f1b2c0e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1437208e-1209-41a1-b349-1d2335c17dfb.pdf",
            "news_date": "2023-02-10 17:26:29",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday, February 10, 2023 Pursuant To Regulations 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In continuation of our letter dated January 30, 2023, we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e., Friday, February 10, 2023 inter alia considered and approved the Unaudited Financial Results for the quarter ended December 31, 2022 based on the recommendation of the Audit Committee. The said Unaudited Financial Results together with the Limited Review Report of the Statutory Auditors dated February 10, 2023 are enclosed herewith. <BR> <BR> The Meeting commenced at 2:30 P.M. and concluded at 5.00 P.M. (IST).<BR> <BR>",
            "news_id": "344800b6-7286-4de2-afaf-c376f8432175",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a305fd95-b366-4e6c-a6d4-9ddb3f988426.pdf",
            "news_date": "2023-02-10 17:22:37",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions",
            "news_body": "Pursuant to the provisions of Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we enclose herewith the disclosure of Related Party Transactions for half year ended September 30, 2022 for your information and records.",
            "news_id": "d37ff83d-7638-438b-9c49-51dfaf151d79",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67d27e0f-4355-47d6-ac20-ebe8425b2222.pdf",
            "news_date": "2022-11-25 20:25:49",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Friday, November 11, 2022 Pursuant To Regulations 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Please find the enclosed file as per the captioned subject for your reference.",
            "news_id": "739f0371-66d6-4cfe-9ed3-61a276479491",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ff7fc1e-b123-4d0b-bd99-a8092f00e738.pdf",
            "news_date": "2022-11-11 15:56:46",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday, November 11, 2022 Pursuant To Regulations 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Please find the enclosed file relating to the captioned subject for your reference.<BR> <BR> The Meeting commenced at 1:30 P.M. and concluded at  3:30 P.M.(IST).<BR>",
            "news_id": "5fc5071c-a9cb-494b-9acd-3c3ff14d14e7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=886973e4-9edf-46f4-a301-fd59b47d803c.pdf",
            "news_date": "2022-11-11 15:43:22",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Monday, August 8, 2022",
            "news_body": "At the Board meeting of the Company held on Monday, August 8, 2022 the Board of Directors considered and approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2022. The said Unaudited Financial Results together with the Limited Review report of the Statutory Auditors dated August 8, 2022 are enclosed herewith.",
            "news_id": "b8346301-a1fc-4a73-98bb-d856921f91d5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb38c200-0059-49dc-a123-24e8d2d033eb.pdf",
            "news_date": "2022-08-08 13:31:16",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions",
            "news_body": "Pursuant to the provisions of Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we enclose herewith the disclosure of Related Party Transactions for half year ended March 31, 2022 for your information and records.",
            "news_id": "a45a914f-a7e2-4ba1-865e-29f1d0dcbab7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a352947c-a38f-427d-9a84-b1a34cbd2c0d.pdf",
            "news_date": "2022-06-09 18:06:33",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Thursday, May 26, 2022",
            "news_body": "The Board of Directors of the Company at their meeting held today i.e., May 26, 2022, has inter-alia:<BR> <BR> 1. Approved the Audited Financial Results of the Company for the quarter and year ended                           March 31, 2022. The said Audited Financial Results together with the Audit report of the Statutory Auditors dated May 26, 2022 are enclosed herewith. <BR> <BR> 2. Recommended Final Dividend of Rs. 8/- per equity share for the financial year 2021-22<BR> <BR> <BR> We also confirm that the Auditor's Report is with unmodified opinion in respect of the Audited Financial Results of the Company for the financial year ended March 31, 2022. <BR>",
            "news_id": "ba4a20b8-8cac-4e01-a763-26380fecea49",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=557fe7eb-5c7e-467d-9851-c14615714fcd.pdf",
            "news_date": "2022-05-26 17:35:17",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Tuesday, February 8, 2022",
            "news_body": "At the Board meeting of the Company held on Tuesday, February 8, 2022 the Board of Directors considered and approved the Unaudited Financial Results of the Company for the quarter ended December 31, 2021. The said Unaudited Financial Results together with the Limited Review report of the Statutory Auditors dated February 8, 2022 are enclosed herewith.",
            "news_id": "f0264075-8e52-4375-a3f7-ebe254cf7b71",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8201139-be16-4a61-97a8-1f60acea9735.pdf",
            "news_date": "2022-02-08 18:09:54",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions",
            "news_body": "Pursuant to the provisions of Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we enclose herewith the disclosure of Related Party Transactions for half year ended September 30, 2021 for your information and records.",
            "news_id": "883ddfb1-d6ab-4cf3-9a14-021b2cc2ed99",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a58c7ce-c149-4fb0-bd61-7c3896013aaa.pdf",
            "news_date": "2021-11-29 11:24:17",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Tuesday, November 9, 2021",
            "news_body": "At the Board meeting of the Company held on Tuesday, November 9, 2021 the Board of Directors considered and approved the Unaudited Financial Results of the Company for the quarter ended September 30, 2021. The said Unaudited Financial Results together with the Limited Review report of the Statutory Auditors dated November 9, 2021 are enclosed herewith.",
            "news_id": "eadf4aef-eb14-4c2d-b312-b44ddd7b5331",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1edda45a-251b-4915-81c6-ff39b44cc6d7.pdf",
            "news_date": "2021-11-09 17:25:05",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Monday, August 9, 2021",
            "news_body": "The Board of Directors of the Company at their meeting held today i.e, August 9, 2021, has inter-alia:<BR> <BR> 1. Approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2021. <BR> The said Unaudited Financial Results together with the Limited Review report of the Statutory Auditors dated August 9, 2021 are enclosed herewith. <BR> <BR> 2. Declared Interim Dividend of Rs. 2 per equity share for the financial year 2021-22<BR> <BR> 3. Fixed August 20, 2021 as the Record Date for determining the entitlement of the shareholders for the payment of aforesaid Interim Dividend<BR>",
            "news_id": "120fe351-b78e-4ecb-bcce-a82be4b2ed7f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fcc3b418-2f62-492a-b83d-ec817356f02b.pdf",
            "news_date": "2021-08-09 14:09:58",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions",
            "news_body": "Pursuant to the provisions of Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we enclose herewith the disclosure of Related Party Transactions for half year ended March 31, 2021 for your information and records.",
            "news_id": "b5d8dffb-2536-4978-a70f-8bcc5a842c15",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7e8e7d3-4138-4766-8cb2-f20c1e14995a.pdf",
            "news_date": "2021-06-02 16:56:04",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Tuesday, May 25, 2021",
            "news_body": "At the Board meeting of the Company held on Tuesday, May 25, 2021 the Board of Directors considered and approved the Audited Financial Results of the Company for the quarter and year ended                           March 31, 2021. The said Audited Financial Results together with the Audit report of the Statutory Auditors dated May 25, 2021 are enclosed herewith. <BR> <BR> We also confirm that the Auditor's Report is with unmodified opinion in respect of the Audited Financial Results of the Company for the financial year ended March 31, 2021. <BR> <BR> The Board meeting concluded at 4.05 p.m",
            "news_id": "154eb083-63a3-40e1-bc29-7f92463eb2e0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc0d1695-401f-43b4-b877-bd08b0c527d8.pdf",
            "news_date": "2021-05-25 16:38:10",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ASTRAZEN",
            "disp": "AstraZeneca Pharma",
            "bse_code": 506820,
            "isin": "INE203A01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Tuesday, May 25, 2021",
            "news_body": "At the Board meeting of the Company held on Tuesday, May 25, 2021 the Board of Directors considered and approved the Audited Financial Results of the Company for the quarter and year ended                           March 31, 2021. The said Audited Financial Results together with the Audit report of the Statutory Auditors dated May 25, 2021 are enclosed herewith. <BR> <BR> We also confirm that the Auditor's Report is with unmodified opinion in respect of the Audited Financial Results of the Company for the financial year ended March 31, 2021. <BR> <BR> The Board meeting concluded at 4.05 p.m<BR>",
            "news_id": "e8c00f8a-3712-40df-9a71-3c6a6e5314c2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=979414ca-3a84-4d30-be20-4547bad494cb.pdf",
            "news_date": "2021-05-25 16:33:36",
            "seo": "astrazeneca-pharma-india-ltd",
            "ltp": 9068,
            "ch": 107.5,
            "pch": 1.1997098376206685,
            "inst": "EQUITY",
            "ts": 0.5,
            "ls": 1,
            "mtp": 1,
            "sid": 5610,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}